Biotech

All Articles

3 biotechs try to defeat the summer heat energy through dropping team

.As biotechs attempt to switch a fresh web page in August, at the very least three companies have ac...

venBio lifts $528M for fifth lifestyle scientific researches VC fund

.Professional equity capital firm venBio has raised an additional half a billion dollars to purchase...

Otsuka spends $800M for Jnana and its own clinical-stage PKU medication

.Otsuka Drug has actually picked up Boston-based Jnana Therapeutics for $800 thousand so the Japanes...

FibroGen gives up 75% of US workers as asset flunks 2 additional trials

.FibroGen is actually drastically restructuring its business, laying off 75% of its U.S. workers as ...

Tracon relax weeks after injectable PD-L1 inhibitor fall short

.Tracon Pharmaceuticals has decided to wane functions weeks after an injectable immune system gate p...

Ideaya bags option on Biocytogen bispecific ADC in $400M bargain

.Ideaya Biosciences is actually wagering $400 million in biobucks that a bispecific antibody-drug co...

Takeda takes $140M reduction on failed epilepsy medication, proclaims FDA operate

.Our team presently recognize that Takeda is intending to discover a path to the FDA for epilepsy me...

VBI Vaccines files for insolvency, seeks resource purchase

.Immunology biotech VBI Injections is actually veering alarmingly close to the defining moment, alon...

Celldex anti-cKIT antibody minimize colonies in one more phase 2 research

.It's not easy to muscle in on a room as very competitive as immunology, but Celldex Therapeutics fe...

Boehringer offers up to $1.3 B for gate prevention biotech

.Boehringer Ingelheim is actually providing to $1.3 billion for Nerio Rehabs and a preclinical immun...